MARLA HOSTETTER KROPF: Open Payments
NPI 1497792295 · TIGARD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 16 payments from 11 companies in 2025. Trend: 2023 $299 · 2024 $121 · 2025 $367
Food & beverage: $347Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $87 |
| Teva Pharmaceuticals USA, Inc. | 1 | $43 |
| ABBVIE INC. | 2 | $43 |
| PFIZER INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $36 |
| Eisai Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: Ozempic, AUSTEDO XR, Wegovy, UBRELVY, Leqembi, SHINGRIX, Cologuard Collection Kit, NURTEC ODT.
Industry payments across OR — which companies pay providers there.
